Loading clinical trials...

Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study) | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT03446586

Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study)

The purpose of the registry/repository is to understand the natural history of tyrosinemia in our region and to provide a mechanism to store data and specimens to support the conduct of future researc...

Lead sponsor: Yassin Abdelghaffar Charity Center for Liver Disease and Research•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Mamdouh A. Ahmed

CONTACT

02-01221707770 dr.yassinabdelghaffar@gmail.com

Related studies

WITHDRAWN

A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients

NCT06227429 · Hereditary Tyrosinemia, Type I

COMPLETED

Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care

NCT02320084 · Hereditary Tyrosinemia, Type I

COMPLETEDPhase 1

Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1)

NCT02750332 · Hereditary Tyrosinemia, Type I

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 10, 2019Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment50

Start dateApr 2019

Last updatedJan 10, 2019

Condition

Hereditary Tyrosinemia, Type I

Locations shown

Professor Yassin Abdel Ghaffar Charity Center for Liver Disease and Research

Madīnat an Naşr, Cairo Governorate

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 10, 2019Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions